The factor V Leiden mutation may predispose women to severe preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 175, Issue 4 I, 1996, Pages 902-905

  Dizon Townson, D S ^a   Nelson, L M ^a   Easton, K ^a   Ward, K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

endothelial cell dysfunction; factor V Leiden mutation; Preeclampsia; thrombosis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; DNA;

CONFERENCE PAPER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; THROMBOEMBOLISM;

EID: 0029999583     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)80022-6     Document Type: Conference Paper

References (27)

1. GA Dekker JIP de Vries PM Doelitzsch PC Huijgens BME von Blomberg C Jakobs Underlying disorders associated with severe early-onset preeclampsia Am J Obstet Gynecol 173 1995 1042 1048
2. RM Bertina BPC Koeleman T Koster FR Rosendaal RJ Dirven H de Ronde Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
3. B. Dahlback Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene Haemostasis 24 1994 139 151
4. PJ Svensson B. Dahlback Resistance to activated protein C as a basis for venous thrombosis New Engl J Med 330 1994 517 522
5. American College of Obstetricians and Gynecologists Management of preeclampsia 1986 The College Washington Technical bulletin No. 91
6. CT. Esmon The roles of protein C and thrombomodulin in the regulation of blood coagulation J Biol Chem 264 1989 4743 4746
7. B Dahlback J. Stenflo The protein C anticoagulant system G Stamatoyannopoulos AW Nienhuis PW Majeurs H Varmus The molecular basis of blood diseases. 1994 Saunders Philadelphia 599 628
8. B. Dahlback Protein S and C4b binding protein: components involved in the regulation of the protein C anticoagulant system Thromb Haemostas 66 1991 49 61
9. M Kalafatis MD Rand KG. Mann The mechanism of inactivation of human factor V and human factor Va by activated protein C J Biol Chem 269 1994 31869 31880
10. SA Friedman E Schiff JJ Emeis GA Dekker BM. Sibai Biochemical corroboration of endothelial involvement in severe preeclampsia Am J Obstet Gynecol 172 1995 202 203
11. SA Friedman CJM de Groot RN Taylor BD Golditch JM. Roberts Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation Am J Obstet Gynecol 170 1994 838 841
12. L Deng K Bremme LO Hansson M. Blomback Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia Obstet Gynecol 84 1994 941 945
13. AA Saleh SF Bottoms FR Gerbasi EF. Mammen Hemostasis and diagnosis of preeclampsia Thromb Res 75 1994 163 171
14. AA Saleh SF Bottoms RA Welch AM Ali FG Mariona EF. Mammen Preeclampsia, delivery, and the hemostatic system Am J Obstet Gynecol 157 1987 331 336
15. AA Kraayenbrink GA Dekker GJ van Kamp HP. van Geijn Endothelial vasoactive mediators in preeclampsia Am J Obstet Gynecol 169 1993 160 165
16. DB Brubaker MG Ross D. Marinoff The function of elevated plasma fibronectin in preeclampsia Am J Obstet Gynecol 166 1992 526 531
17. JM Roberts RN Taylor TJ Musci GM Rodgers CA Hubel MK. McLaughlin Preeclampsia: an endothelial cell disorder Am J Obstet Gynecol 161 1989 1200 1204
18. K Benirschke P Kaufman Pathology of the human placenta. 1995 Springer-Verlag New York
19. DG McKay SJ Merrill AE Weiner AT Hertig DE. Reid Pathologic anatomy of eclampsia, bilateral renal cortical necrosis, pituitary necrosis and other acute fatal complications of pregnancy and its possible relationship to the generalized Shwartzman phenomenon Am J Obstet Gynecol 66 1953 507 539
20. DG. McKay Hematologic evidence of disseminated intravascular coagulation in eclampsia Obstet Gynecol Surv 27 1972 399 417
21. EW. Page On the pathogenesis of preeclampsia Br J Obstet Gynaecol 79 1972 883 894
22. P Vassali RH Morris RT. McCluskey The pathogenic role of fibrin deposition in the glomerular lesions of toxemia of pregnancy J Exp Med 118 1963 467 478
23. F Arias R. Mancilla-Jimenez Hepatic fibrinogen deposits in preeclampsia N Engl J Med 295 1976 578 582
24. L Corash Laboratory evaluation of hemostasis RK Laros Jr Blood disorders in pregnancy 1986 Lea & Febiger Philadelphia 125 149
25. M Hellgren PJ Svensson B. Dahlback Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives Am J Obstet Gynecol 173 1995 210 213
26. G Cook ID Walker F McCall JA Conkie IA. Greer Familial thrombophilia and activated protein C resistance: thrombotic risk in pregnancy? Br J Haematol 87 1994 873 875
27. JP Vandenbroucke T Koster E Briet PH Reitsma RM Bertina FR. Rosendaal Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation Lancet 344 1994 1453 1457